Document Detail

Adjuvant Pharmacotherapy in the Management of Elderly Patients with Pancreatic Cancer.
MedLine Citation:
PMID:  23338795     Owner:  NLM     Status:  Publisher    
Pancreatic ductal adenocarcinoma (PDAC) is the fourth or fifth leading cause of death from cancer in Western industrialized countries. Surgical resection is the only chance of cure, but only 15-20 % of cases are potentially resectable at presentation, and despite complete resection, the overall prognosis remains relatively poor. Adjuvant therapy has modestly improved cure rates. The majority of patients with pancreatic cancer are over the age of 65 years. But this age group is underrepresented within clinical trials, and it is unknown whether older patients achieve similar results to younger ones in terms of survival and treatment tolerance. In addition, there are no clinical trials dedicated to the elderly. Retrospective studies coming from the non-resectable setting provide some understanding on outcomes in older patients with PDAC. To date, we can reasonably argue that selected elderly patients with PDAC can benefit from curative surgery and postoperative chemotherapy as do their younger counterparts, without a significant increase in morbidity and mortality. Gemcitabine should be preferred to 5-fluorouracil on the basis of a better risk-benefit balance.
Raphaël Maréchal; Anne Demols; Jean-Luc Van Laethem
Related Documents :
3610705 - Radiotherapy in the management of locally advanced breast cancer.
14965625 - What is the evidence for a reduced risk of local recurrence with age among older patien...
23528905 - Ptosis: a rare presentation of hodgkin lymphoma.
24257655 - Angiosarcomas of primary gynecologic origin: a clinicopathologic review and quantitativ...
24055405 - Penile metastases of rectal adenocarcinoma.
19418495 - The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemorad...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-22
Journal Detail:
Title:  Drugs & aging     Volume:  -     ISSN:  1170-229X     ISO Abbreviation:  Drugs Aging     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9102074     Medline TA:  Drugs Aging     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Gastroenterology, GI Cancer Unit, Erasme University Hospital, Université Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Improving Epistemological Beliefs and Moral Judgment Through an STS-Based Science Ethics Education P...
Next Document:  Safety and Efficacy of Thrombolysis with Intravenous Alteplase in Older Stroke Patients.